Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : AMERICAN BIOMED, Minimally Invasive Technology (ABMI) -- Ignore unavailable to you. Want to Upgrade?

To: Dr David Summers who wrote (1569)	8/2/1998 5:22:00 PM
From: Ray Tarke	Read Replies (1) \| Respond to of 2887

Hello David, A great time to average down or accumulate ! Blue Skies are coming. Regards, R.T

To: Dr David Summers who wrote (1569)	8/2/1998 7:29:00 PM
From: Russel W. Kennel	Respond to of 2887

Referring to my own post #949, I do not believe that the current market weakness is due to the company's detractors, but rather the detractors are a symptom of ABMI's own internal problems which I still maintain must be solved if the company is to become successful. The stock market is still a tug of war between the buyers, sellers and manipulators, and will IMHO, sink to the lowest common denominator of the trading outcomes. I wonder how Rash can personally be effective if he is unable to get the matter of Dr. Summers out of the way by issuing him a few shares and putting the matter to rest. His failure to do this to me is an indication of his and the boards' personal and business morass from which they seem unable to extricate themselves. I'm sure there are other financial considerations, but I want to see a company which is singlemindedly able to pursue its mission even if it has to make a small payoff in order to honor past commitments in order to do so. So, yes, I did take the advice of those who replied to my original post and did sell in the $.80 range. But I am interested in good emerging bio-tech companies and continue to follow ABMI. Finally, I am still waiting with interest Dr. Summers, for you to make several cogent points from a business standpoint, as to what the chances of success or failure ABMI has relative to other emerging bio-techs in the areas of product success, marketing or being bought out. You have been asked this question in connection with "emotional agenda" and now I am re-stating the question from a purely business point of view. Thanks! Russ

To: Dr David Summers who wrote (1569)	8/2/1998 7:34:00 PM
From: Meisterama	Respond to of 2887

Dr. Summers, please reread some of your posts from the past few months. I seem to recall a number of bizarre remarks. These include, I think: the idiotic suggestion of a reverse stock split being imminent, to be followed by the collapse of this stock; egotistical accusation that ABMI is not developing certain lucrative products out of "shame"; unsupported and foolish statement that huge blocks of stock are being given to dealers as the only way they could be induced to sell ABMI products; and a mail-order-MBA analysis of the current equity line as a dilutive "stock laundry". None of those statements makes sense or has been supported by fact. If you would like to intelligently argue these points, go ahead and make your case, and I will respond. You have thus far seen fit to simply state these off-the-cuff idiocies without bothering to offer any rational argument to support them. Maybe you view your glib posts as attacks on management only, but I view reckless dissemination of misinformation as a poisoning of investors against this stock. And I surely do not feel sorry for you when you are attacked personally or otherwise, as your purpose in being here, despite what you have repeatedly tried to make us believe, is made clear by your highly negative and misinformation-filled posting history.